Infliximab associated new-onset psoriasis.
Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.
Penn State Hershey Medical Center, Department of Dermatology, Hershey, PA 17033, USA. dadams@psu.edu
David R
DR
Adams
Tamy
T
Buckel
Jennifer A
JA
Sceppa
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab